Alkermes

Alkermes plc is a biopharmaceutical company that focuses on central nervous system diseases. The company is the result of a merger in September 2011 between Alkermes, Inc. , and Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc.